MedTrace Logo

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

NCT00404209 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2024-05-30

No results posted yet for this study

Summary

To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

Conditions

  • Retinal Detachment

Interventions

PROCEDURE

Vitrectomy

pressurized 23GA vitrectomy with a 3D system

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Hugo Quiroz-Mercado, MD · Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"

  • Raul Velez-Montoya, MD · Asociación para Evitar la Ceguera en México

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2007-03-31
Completion
2008-02-29

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00404209 on ClinicalTrials.gov